OncologyEducation presents MedOncNow podcast

OncologyEducation presents MedOncNow

OncologyEducation

OncologyEducation, in partnership with Dr. Shaqil Kassam, is proud to present the MedOncNow podcast. Hosted by Dr. Kassam, MedOncNow offers critical insights on hot topics in medical oncology. From emerging therapies to new standards of care, MedOncNow features discussions with leading oncology experts who share relevant, practical information you can incorporate into your practice.

23 Episodes

A Waterfall of Options - Perioperative Bladder Cancer - Part 2
9/23/2026
30:05
In this episode of MedOncNow, Dr. Aly-Khan Lalani, walks us through the rapidly evolving landscape of perioperative therapy for muscle-invasive bladder cancer — two practice-changing trials, two different patient populations, and a whole lot of practical decisions that no algorithm will make for you. This is particularly timely given there is an access program for this Regimen.
A Waterfall of Options - Perioperative Bladder Cancer - Part 1
9/8/2026
32:46
In this episode of MedOncNow, Dr. Aly-Khan Lalani, walks us through the rapidly evolving landscape of perioperative therapy for muscle-invasive bladder cancer — two practice-changing trials, two different patient populations, and a whole lot of practical decisions that no algorithm will make for you. This is particularly timely given there is an access program for this Regimen.
Don't miss an episode of “OncologyEducation presents MedOncNow” and subscribe to it in the GetPodcast app.
Summiting Perioperative Gastric Cancer - With Dr. Howie Lim
6/9/2026
32:36
In this episode, Dr. Howard Lim takes us through the peri-operative management of Gastric/GEJ Adenocarcinoma. This is particularly timely given Ontario now has funded access to the Matterhorn regimen, with the hopes of other provinces to follow.
Abema and Ribo - Adjuvant High Risk EBC with Dr. Aalok Kumar
5/13/2026
29:58
In this episode, Dr. Aalok Kumar takes us through the practical aspects of choosing between the available adjuvant intensification options in "High Risk" HR+, HER2 - Early Breast Cancer. This is timely given there is public funding for Abemaciclib and PSP support for Ribociclib.
Targeted therapy in Cholangiocarcinoma - Part 2 - Ivosidenib
4/23/2026
25:08
In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib (PART 1) to target FGFR2 fusions and Ivosidenib (PART 2) for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate these into practice.
Targeted therapy in Cholangiocarcinoma - Part 1 - Pemigatinib
4/2/2026
31:30
In this episode, Dr. Arndt Vogel takes us through targeted therapy in Biliary Tract Cancers. As we now have access to Pemigatinib to target FGFR2 fusions and Ivosidenib for IDH1 mutated cholangiocarcinoma, I thought it important to discuss how to incorporate these into practice.
You Are What You Eat - Diet and Cancer with Dr. Urvi Shah
3/18/2026
35:15
In this episode, Dr. Urvi Shah takes us through how to optimize diet in cancer treatment and prevention.
Targeting HER2 Alterations in NSCLC with Dr. Barbara Melosky
2/6/2026
33:51
In this episode, Dr. Barb Melosky takes us through practical aspects of using HER2 targeted agents in HER2 altered advanced NSCLC. This is particularly timely given we now have access through company sponsored SAP programs for both Zongertinib and Sevabertinib.
Choosing in Advanced NSCLC - Without AGA, and EGFR+ with Dr. Natasha Leighl
1/19/2026
38:55
In this episode, Dr. Natasha Leighl takes us through practical aspects of choosing treatments in advanced NSCLC without AGA and then in EGFR + NSCLC. We discuss treatments that are routinely available in clinic.
Sequencing in Advanced Colorectal Cancer - with Dr. Scott Berry
12/23/2025
44:41
In this episode, Dr. Scott Berry takes us through practical discussions on sequencing the increasing available treatment options for Advanced Colorectal cancer.

Get the whole world of podcasts with the free GetPodcast app.

Subscribe to your favorite podcasts, listen to episodes offline and get thrilling recommendations.

© radio.de GmbH 2026

MADSACK